In-situ cryo-immune engineering of tumor microenvironment with cold-responsive nanotechnology for cancer immunotherapy

Cancer immunotherapy that deploys the host’s immune system to recognize and attack tumors, is a promising strategy for cancer treatment. However, its efficacy is greatly restricted by the immunosuppressive (i.e., immunologically cold) tumor microenvironment (TME). Here, we report an in-situ cryo-imm...

Descripción completa

Detalles Bibliográficos
Autores principales: Ou, Wenquan, Stewart, Samantha, White, Alisa, Kwizera, Elyahb A., Xu, Jiangsheng, Fang, Yuanzhang, Shamul, James G., Xie, Changqing, Nurudeen, Suliat, Tirada, Nikki P., Lu, Xiongbin, Tkaczuk, Katherine H. R., He, Xiaoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873931/
https://www.ncbi.nlm.nih.gov/pubmed/36693842
http://dx.doi.org/10.1038/s41467-023-36045-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873931/
https://www.ncbi.nlm.nih.gov/pubmed/36693842
http://dx.doi.org/10.1038/s41467-023-36045-7

Ejemplares similares